At this point in time two different phakic intraocular lenses have emerged. First the Verisyse Lens was released by AMO (American Medical Optics) and then in December of 2006 the implantable contact lens known as the Visian ICL was approved by the FDA for use in cases of myopia ranging up to -15 diopters of myopia. Dr. William Hines is certified for surgical application with both of these lenses and will be happy to discuss either of these intraocular lenses at anytime. Be sure to consult a qualified ophthalmologist before trying to make an opinion as to the best lens for yourself. If you are highly myopic and LASIK eye surgery has not been an option for you please schedule an eye exam to learn more. These lenses have been bringing the same lifestyle benefits that LASIK has provided to millions of people.
Denver LASIK expert William Hines MD expands treatable range for nearsighted patients with the NEW Visian ICL
Introducing a solution for patients with high amounts of nearsightedness. The ICL is a revolutionary refractive lens that can correct vision up to –15 diopters of nearsightedness. The Visian ICL is a new refractive surgery technology (like LASIK, or Epi-LASIK). The Visian ICL is a phakic intraocular lens ("phakic" means that the natural crystalline lens is left in the eye). Visian ICL is a good alternative for Denver LASIK. The doctors at Hines-Sight were among the first to perform the Visian ICL eye surgery and have extensive experience with the procedure.
The Visian ICL offers superb quality of vision while maintaining excellent contrast sensitivity. Unlike other refractive surgeries, the Visian ICL is reversible. The Visian Implantable Contact Lens is FDA approved and over 75,000 have been implanted to date. Visian ICL surgery does not permanently alter the shape or structure of the front of the eye and is inserted through a very small (2.8 millimeter), self-sealing (no stitches required) incision allowing good vision shortly after surgery and is very quick healing. All other FDA approved phakic intraocular lenses require 6-millimeter incisions, which heal much slower and often cause considerable astigmatism.
The ICL procedure has been repeatedly improved through years of studies and continued refinement. This lens is a posterior chamber implant that is situated behind the iris and in front of the natural crystalline lens. The surgery is performed on an outpatient basis, which means that a patient has surgery and leaves the same day. This lens has actually been used in Europe for the last ten years. It has been under investigation by the FDA during this time period where surgeons were implanting this in Europe. By the time of the much anticipated FDA approval, there was significant positive time tested data on this lens implant.
This lens implant surgery is actually very similar to the cataract surgery process which has been a highly successful surgical procedure for 20 years. Prior to the ICL surgery Dr. Hines will make two microscopic holes in the iris. Your eye will be numbed with a light, topical or local anesthetic. Once the eye is numbed the surgeon will make 2 side port incisions and one main temporal incision that is critical to the insertion process. Next the surgeon will insert the ICL through the main temporal incision and place the lens behind the iris and in front of the crystalline lens. This insertion procedure is typically performed one eye at a time. There is very little discomfort and normally no pain associated with the procedure. Some drops or perhaps oral medication may be prescribed and a visit is usually scheduled the day after surgery. Patients will be advised to arrange for someone to drive them to and from surgery.
Individuals who suffer from extreme nearsightedness will have a solution for their poor vision. The ICL provides an opportunity to those individuals who are not candidates for LASIK eye surgery. Some people cannot have LASIK for reasons ranging from high prescriptions to thin corneas. The ICL will now give these patients the opportunity to experience the same lifestyle change that lasik has brought to millions.
You could be a good ICL candidate if:
The Verisyse Phakic IOL is an alternative to the Visian ICL and laser eye surgery. We offer this surgery to our highly nearsighted patients at our Denver, Colorado surgery location. The Verisyse Phakic intraocular lens ("Phakic" means that the natural crystalline lens is left in the eye) is designed for those who may not be a candidate for laser vision correction due to very high myopia or very thin corneas, and in the future high farsightedness. Its advantage is that the natural lens remains in place to focus from far to near in a natural way. It is intended for younger patients who can still focus well. The Verisyse Phakic IOL is still appropriate for older patients, greater than 45 years old, who can still focus but to a reduced degree.
The procedure involves placing a properly selected intraocular lens implant behind the cornea and in front of the iris to greatly diminish dependency on glasses or contact lenses, often eliminating them. Often patients who have astigmatism may require further laser vision correction to "tweak" their vision.
Implanting the Verisyse Phakic IOL is an outpatient procedure that takes around 30 minutes. Usually one eye is treated at a time. To begin the surgery drops will be placed in the eye in order to reduce the pupil size. For better access to your eye Dr. Hines will use an instrument to comfortably hold your eyelids open during the procedure. The surgery is done under local anesthesia so the procedure is virtually painless. Next, a small incision is made in the cornea for the Verisyse lens to be placed in the space between the iris and the cornea. The lens is then gently attached to the iris (the colored part of the eye) to hold the lens in place. The small incision is then closed with microscopic stitches that dissolve on their own. A shield will then be placed over your eye to protect it until you are seen the following morning for the first postoperative exam.
Even though this Phakic IOL has been recently approved for use, it has been safely used in over 150,000 patients and is the safest of all intraocular lens implants used. Although the Verisyse Phakic IOL is intended to be permanent, the procedure is reversible if desired or necessary.
Myopic or nearsighted individuals typically have problems seeing well at a distance and are forced to wear glasses or contact lenses. The nearsighted eye is usually longer than a normal eye and the cornea may also be steeper. As a result, when light passes through the cornea and the lens it is focused in front of the retina, making distant images appear blurred. Myopia or nearsightedness is perhaps the most common vision disorder known to ophthalmologists. For years glasses and contact lenses have been the typical protocol for correcting myopia so that light can focus on the retina. In most circumstances the myopic patient has a plethora of very good options for correcting myopia such as glasses, contact lenses, Intacs corneal ring segments and laser vision correction. If someone’s specific myopic problem is severe, also know as high myopia or extreme nearsightedness, options for correcting vision can be limited.
The main treatment options include a traditional set of glasses which may be thick and the NEW Visian ICL also known as the implantable contact lens or implantable collamer lens. For patients with smaller amounts of myopia traditional LASIK eye surgery should be considered and discussed with an ophthalmologist prior to considering intraocular eye surgery.
* Refractive surgery procedures such as LASIK or ICL may reduce the need for glasses, but do not decrease the risk associated with being highly myopic.